Company: ICUI
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000883984-25-000016
Chunk: 7

Company: ICU MEDICAL INC/DE
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 2
Chunk 7
---
 the impact of fluctuations in foreign currency exchange rates that occurred between the comparative periods. We provide constant currency information to enhance the visibility of underlying business trends, excluding the effects of changes in foreign currency translation rates. We believe this information is useful to investors to facilitate comparisons and better identify trends in our business. Our constant currency revenues reflect current period local currency revenues at prior period's average exchange rates. We consistently apply this approach to revenues for all currencies where the functional currency is not the U.S. dollar. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Revenues on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with GAAP.

Consumables

    The following table summarizes our total Consumables revenue (in millions, except percentages):

Three months ended March 31,20252024$ Change% ChangeConsumables revenue (GAAP)$266.2 $244.1 $22.1 9.1 %Impact of foreign currency exchange rate changes3.0 Consumables revenue on a constant currency basis (non-GAAP)$269.2 $ Change in constant currency$25.1 % Change in constant currency10.3 %

42

Consumables revenue increased for the three months ended March 31, 2025, as compared to the same period in the prior year, primarily due to new customer installations and increased demand for our Infusion Consumables, Vascular Access and Oncology product lines.

Infusion Systems

    The following table summarizes our total Infusion Systems revenue (in millions, except percentages):

Three months ended March 31,20252024$ Change% ChangeInfusion Systems (GAAP)$166.3 $157.3 $9.0 5.7 %Impact of foreign currency exchange rate changes3.0 Infusion Systems on a constant currency basis (non-GAAP)$169.3 $ Change in constant currency$12.0 % Change in constant currency7.6 %

Infusion Systems revenue increased for the three months ended March 31, 2025, as compared to the same period in the prior year, primarily due to increased sales of LVP pump hardware and dedicated sets.

Vital Care

    The following table summarizes our total Vital Care revenue (in millions, except percentages):

Three months ended March 31,20252024$